IFN-β produced by MSCs inhibits the growth of malignant cells such as breast cancer, prostate cancer, bronchioloalveolar carcinoma, lung cancer, tongue squamous cell carcinoma, melanoma, lung metastatic melanoma, and pancreatic tumors metastases to the lung [31, 43–48]. Here, IFNB1 is linked to pancreatic neoplasm.